Jens Dannull

4.9k total citations · 1 hit paper
48 papers, 4.0k citations indexed

About

Jens Dannull is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jens Dannull has authored 48 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 25 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Jens Dannull's work include Immunotherapy and Immune Responses (34 papers), CAR-T cell therapy research (12 papers) and RNA Interference and Gene Delivery (12 papers). Jens Dannull is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), CAR-T cell therapy research (12 papers) and RNA Interference and Gene Delivery (12 papers). Jens Dannull collaborates with scholars based in United States, Germany and Switzerland. Jens Dannull's co-authors include Johannes Vieweg, Eli Gilboa, Donna Yancey, Doris Coleman, Axel Heiser, Donna Niedzwiecki, Zhen Su, Philipp Dahm, Karin Moelling and David Boczkowski and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Jens Dannull

48 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

2005 753 citations Jens Dannull Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jens Dannull United States	24	2.9k	1.8k	1.5k	519	292	48	4.0k
Jean‐François Fonteneau France	33	2.7k 1.0×	1.1k 0.6×	980 0.6×	431 0.8×	387 1.3×	75	3.7k
Birthe Sauter United States	9	4.5k 1.6×	1.9k 1.1×	1.3k 0.9×	387 0.7×	130 0.4×	10	5.6k
Carlo Heirman Belgium	47	4.8k 1.7×	3.2k 1.7×	2.2k 1.4×	933 1.8×	172 0.6×	118	6.7k
Edward E. Lemmens United States	16	4.5k 1.6×	1.3k 0.7×	1.4k 0.9×	242 0.5×	238 0.8×	23	5.2k
Amanda L. Marzo United States	28	4.1k 1.4×	562 0.3×	1.1k 0.8×	203 0.4×	151 0.5×	51	4.9k
Steve Pascolo Switzerland	35	2.4k 0.9×	2.5k 1.4×	795 0.5×	660 1.3×	127 0.4×	100	4.1k
Amy Hobeika United States	34	2.5k 0.9×	2.0k 1.1×	1.7k 1.1×	318 0.6×	43 0.1×	90	4.2k
Ellen I. H. van der Voort Netherlands	28	4.7k 1.6×	967 0.5×	1.5k 1.0×	367 0.7×	125 0.4×	37	5.4k
Richard Harrop United Kingdom	29	1.1k 0.4×	660 0.4×	1.0k 0.7×	436 0.8×	127 0.4×	66	2.5k
Helen Sabzevari United States	27	2.3k 0.8×	689 0.4×	1.7k 1.1×	209 0.4×	59 0.2×	55	3.4k

Countries citing papers authored by Jens Dannull

Since Specialization

Citations

This map shows the geographic impact of Jens Dannull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Dannull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Dannull more than expected).

Fields of papers citing papers by Jens Dannull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Dannull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Dannull. The network helps show where Jens Dannull may publish in the future.

Co-authorship network of co-authors of Jens Dannull

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Dannull. A scholar is included among the top collaborators of Jens Dannull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Dannull. Jens Dannull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Nair, Smita K., Georgia D. Tomaras, Ana Paula Sales, et al.. (2014). High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes. Scientific Reports. 4(1). 4632–4632. 8 indexed citations

2.

Dannull, Jens, Nancy Haley, Gary E. Archer, et al.. (2013). Melanoma immunotherapy using mature DCs expressing the constitutive proteasome. Journal of Clinical Investigation. 123(7). 3135–3145. 58 indexed citations

3.

Dannull, Jens, Smita K. Nair, Enyu Ding, et al.. (2013). Local secretion of IL-12 augments the therapeutic impact of dendritic cell–tumor cell fusion vaccination. Journal of Surgical Research. 185(2). 904–911. 15 indexed citations

4.

Pruitt, Scott K., David Boczkowski, Nicole de Rosa, et al.. (2011). Enhancement of anti‐tumor immunity through local modulation of CTLA‐4 and GITR by dendritic cells. European Journal of Immunology. 41(12). 3553–3563. 64 indexed citations

5.

Dahm, Philipp, et al.. (2006). In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy. Cancer Research. 66. 941–941. 7 indexed citations

6.

Su, Zhen, Jens Dannull, Benjamin Yang, et al.. (2005). Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer. The Journal of Immunology. 174(6). 3798–3807. 273 indexed citations

7.

Dannull, Jens. (2005). Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. Journal of Clinical Investigation. 115(12). 3623–3633. 753 indexed citations breakdown →

8.

Vieweg, Johannes & Jens Dannull. (2005). Technology Insight: vaccine therapy for prostate cancer. Nature Clinical Practice Urology. 2(1). 44–51. 19 indexed citations

9.

Abdel-Wahab, Zeinab, Jens Dannull, Smita K. Nair, et al.. (2004). Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4. The Journal of Immunology. 172(11). 7162–7168. 52 indexed citations

10.

Vieweg, Johannes, Z.W. Su, & Jens Dannull. (2004). Enhancement of antitumor immunity following depletion of CD4⁺CD25⁺ regulatory T cells. Journal of Clinical Oncology. 22(14_suppl). 2506–2506. 4 indexed citations

11.

Nair, Smita K., C. McLaughlin, Alon Z. Weizer, et al.. (2003). Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation. The Journal of Immunology. 171(11). 6275–6282. 134 indexed citations

12.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 23 indexed citations

13.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 419 indexed citations

14.

Dannull, Jens, Thomas Cerny, Daniel Ackermann, & Marcus Groettrup. (2000). Current Status of Dendritic Cell-Based Tumor Vaccination. Oncology Research and Treatment. 23(6). 544–551. 3 indexed citations

15.

Mulders, Peter, Cho-Lea Tso, Shen Pang, et al.. (1998). Adenovirus-Mediated Interleukin-2 Production by Tumors Induces Growth of Cytotoxic Tumor-Infiltrating Lymphocytes Against Human Renal Cell Carcinoma. Journal of Immunotherapy. 21(3). 170–180. 8 indexed citations

16.

Dannull, Jens & Arie S. Belldegrun. (1997). Development of gene therapy for prostate cancer using a novel promoter of prostate‐specific antigen. British Journal of Urology. 79(S1). 97–103. 22 indexed citations

17.

Moelling, Karin, Jens Dannull, P. Beimling, et al.. (1994). Stimulation of Ki‐ras Ribozyme Activity by RNA Binding Protein, NCp7, in Vitro and in Pancreatic Tumor Cell Line, Capan 1^a. Annals of the New York Academy of Sciences. 733(1). 113–121. 2 indexed citations

18.

Müller, Gerd, Bettina Strack, Jens Dannull, et al.. (1994). Amino Acid Requirements of the Nucleocapsid Protein of HIV-1 for Increasing Catalytic Activity of a Ki-ras Ribozyme in Vitro. Journal of Molecular Biology. 242(4). 422–429. 39 indexed citations

19.

Surovoy, Andrej, Jens Dannull, Karin Moelling, & Günther Jung. (1993). Conformational and Nucleic Acid Binding Studies on the Synthetic Nucleocapsid Protein of HIV-1. Journal of Molecular Biology. 229(1). 94–104. 55 indexed citations

20.

Dannull, Jens, et al.. (1993). The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides. Biochimie. 75(1-2). 71–78. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact